NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Fluoxetine
Overview
Authors
Affiliations
Healy D, Le Noury J, Mangin D Int J Risk Saf Med. 2018; 29(3-4):125-134.
PMID: 29733030 PMC: 6004900. DOI: 10.3233/JRS-180744.
Aggarwal A, Jethani S, Rohatgi R, Kalra J J Clin Diagn Res. 2016; 10(3):AF01-3.
PMID: 27134853 PMC: 4843239. DOI: 10.7860/JCDR/2016/16482.7376.
In vitro modulation of estrogen receptor activity by norfluoxetine.
Lupu D, Pop A, Cherfan J, Kiss B, Loghin F Clujul Med. 2015; 88(3):386-90.
PMID: 26609274 PMC: 4632900. DOI: 10.15386/cjmed-476.
Nikoui V, Ostadhadi S, Takzare N, Nabavi S, Giorgi M, Bakhtiarian A ScientificWorldJournal. 2013; 2013:382434.
PMID: 24298213 PMC: 3835609. DOI: 10.1155/2013/382434.
Nijenhuis C, Ter Horst P, van Rein N, Wilffert B, de Jong-van den Berg L Br J Clin Pharmacol. 2011; 73(1):126-34.
PMID: 21848990 PMC: 3248262. DOI: 10.1111/j.1365-2125.2011.04081.x.